Researchers have created a new RNAi vector called pDECAP that allows for tissue-specific suppression of gene expression in mammals. This breakthrough technology enables the efficient exploration of gene function by avoiding the antiviral response to foreign dsRNA, a major complication in mammalian RNAi research.
SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateMay 31, 2003
Research reveals that survivors of childhood cancer are experiencing significant sleep disturbances even years after completing treatment. The University of Minnesota study aims to investigate the causes and effects of these issues.
Researchers developed a new method to assess breast cancer patients' prognosis by analyzing 185 genes. The study found that tumors with specific gene expressions can predict long-term survival, even among women with multiple positive nodes.
A phase II study of a multiepitope CD8 T-cell vaccine has demonstrated promising results, inducing an immune response in 32% of patients with metastatic melanoma. The vaccine showed significant correlations with non-progression of disease and longer survival rates.
SourceUniversity of Pittsburgh Medical Center·DateMay 31, 2003
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A study by Chandra P. Belani and colleagues found that elderly patients with advanced NSCLC can tolerate combination therapy safely and effectively, with median survival rates comparable to those of younger patients. The treatment regimens used in the study were weekly paclitaxel in combination with full doses of carboplatin.
SourceUniversity of Pittsburgh Medical Center·DateMay 31, 2003
Scientists have successfully induced the growth of new sensory hair cells in adult guinea pigs using gene therapy. The Math1 gene was inserted into non-sensory epithelial cells lining the inner ear, leading to the formation of new hair cells and attracting the growth of new fibers from auditory neurons.
SourceMichigan Medicine - University of Michigan·DateMay 31, 2003
In a Phase II clinical trial, C225 and docetaxel combination achieved a 25.5% tumor shrinkage rate in advanced non-small cell lung cancer patients, significantly higher than the median response rate of 5-10%. The results are encouraging and suggest further development of this treatment approach.
SourceUniversity of Texas M. D. Anderson Cancer Center·DateMay 31, 2003
A study by Duke University Medical Center researchers found that muscle capillaries respond differently to exercise in men and women. Women's skeletal muscle increased in capillary density after 24 weeks of supervised exercise training, while men did not. Both genders showed similar improvements in exercise capacity.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers identify Plcg1 as a crucial regulator of arterial cell fate during development, contradicting previous assumptions about blood vessel formation. The study uses zebrafish as a model organism to uncover novel insights into vascular development and its potential applications in human disease.
SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateMay 31, 2003
A Phase II study shows that administering ADVEXIN, a p53 drug, directly to tumors can improve the results of neoadjuvant chemotherapy in locally advanced breast cancer. The treatment resulted in dramatic tumor shrinkage and minimal residual tumor cells.
SourceUniversity of Texas M. D. Anderson Cancer Center·DateMay 31, 2003